Fusion Antibodies plc (AIM:FAB)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 5.75
0.00 (0.00%)
Nov 5, 2026, 4:11 PM GMT
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 7.2 million as of November 5, 2026. It is the 41,538th most valuable company in the world and the 925th biggest in the United Kingdom. Its market cap has decreased by 50.34% in one year.
Market Cap
7.20M
Enterprise Value
6.48M
Revenue
2.11M
Global Rank
Country Rank
#925 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 7.20M, a decrease of -73.62%. That is a compound annual growth rate of -13.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 7.20M | -54.77% |
| Dec 31, 2025 | 15.91M | 135.22% |
| Dec 31, 2024 | 6.76M | 167.72% |
| Dec 29, 2023 | 2.53M | -78.42% |
| Dec 30, 2022 | 11.71M | -59.09% |
| Dec 31, 2021 | 28.62M | -9.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford BioDynamics | 13.68M |
| SkinBioTherapeutics | 13.67M |
| Thalia Therapeutics | 10.65M |
| Genflow Biosciences | 10.44M |
| Aptamer Group | 9.34M |
| Palatin Technologies | 7.29M |
| CRISM Therapeutics | 7.09M |
| Solvonis Therapeutics | 6.47M |